REGENXBIO ANNOUNCES REGULATORY UPDATE ON RGX-121 BLA FOR MPS II
REGENXBIO INC - FDA ISSUES COMPLETE RESPONSE LETTER FOR RGX-121
REGENXBIO INC - PLANS TO RESUBMIT BLA FOR RGX-121
REGENXBIO INC - REQUESTS TYPE A MEETING WITH FDA TO DISCUSS RGX-121 CRL
Source text: ID:nPn7Q6Lrra
Further company coverage: RGNX.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.